Twinlab Consolidated Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
May 15, 2019 at 05:17 pm
Share
Twinlab Consolidated Holdings, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was USD 19.971 million compared to USD 19.665 million a year ago. Operating loss was USD 4.786 million compared to USD 4.647 million a year ago. Net loss was USD 8.784 million compared to USD 4.958 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 0.03 a year ago.
Twinlab Consolidated Holdings, Inc. is a marketer, distributor and direct-to-consumer retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty store retailers, on-line retailers, and websites. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Through NutraScience Labs, it also provides services between private label distributors and contract manufacturers. Its services business involved the facilitation of manufacture of custom products. Its products include vitamins, minerals, resveratrol, collagen, keratin, skincare and sports nutrition products primarily under the Twinlab, Reserveage and ResVitale brands. It also markets and sells diet and energy products under the Metabolife brand and a full line of herbal teas under the Alvita brand.
TWINLAB CONSOLIDATED HOLDINGS, INC. 
